REIMBURSEMENT GUIDE
LINQ FAMILY OF ICMs
Hospital & Physician Coding, Coverage, & Payment
February 2021
The LINQ family of Insertable Cardiac Monitors (ICMs) are subcutaneous cardiac rhythm monitors (SCRMs), also known as implantable loop recorders (ILRs). The reimbursement information contained in this document refers to policies for all SCRM/ILRs.
Overview
FDA-cleared Indications
The Reveal LINQ™ and LINQ II™ Insertable Cardiac Monitors (ICMs), referred to throughout this Guide as the "LINQ family of ICMs", are insertable, automatically activated and patient-activated monitoring systems that record subcutaneous ECG and are indicated in the following cases:
- Patients with clinical syndromes or situations at increased risk of cardiac arrhythmias
- Patients who experience transient symptoms such as dizziness, palpitation, syncope, and chest pain that may suggest a cardiac arrhythmia
The device has not been tested specifically for pediatric use.
2021 Updates for LINQ Family of ICMs
Supervision Requirements Update
- Effective January 1, 2021, CMS permits non-physician practitioners [such as nurse practitioners (NPs) and physician assistants (PAs)] to supervise diagnostic tests (including CIED management) ONLY in states where it is allowed by state law and scope of practice.
- Previously, CMS permitted non-physician practitioners to order diagnostic tests (including CIED management) but the regulations did not address whether these practitioners could supervise others who furnished diagnostic tests.
Coding Update
- In late 2020, the American Medical Association (AMA) CPT® Editorial Panel announced approval of a new Category III CPT® code to describe remote programming of subcutaneous cardiac rhythm monitors. The new code will be effective July 1, 2021.
- The existence of a Category III CPT® code does not guarantee payment. Individual payers will determine payment based upon their own criteria and policies.
Code | Description |
---|---|
0650T | Programming device evaluation (remote) of subcutaneous cardiac rhythm monitor system with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified healthcare professional. |
Prior Authorization
Seeking prior authorization (sometimes referred to as pre-authorization, pre-certification, or prior approval) from the patient's payer for the insertion of a subcutaneous cardiac rhythm monitor (SCRM)/implantable loop recorder (ILR) device for all payers other than traditional Medicare is encouraged. Traditional Medicare does not require, nor does it provide, prior authorization.
This section is not intended as a guide through prior authorization, but rather depicts a simplified version of the prior authorization process for your convenience. The requirements vary by payer. Check with the payer regarding their specific processes. All interactions with private payers should be performed by specially trained personnel. A prior authorization does not guarantee coverage.
Definition
Prior authorization is approval from a health plan that may be required prior to a service or prescription in order for that service or prescription to be potentially covered by the plan.
Steps in the Prior Authorization Process
Step 1: Collect Information
- Collect all patient, physician, and payer information.
- Patient's name
- Insurance ID card/payer information
- Physician/facility information (NPI and Tax ID numbers)
- Obtain patient consent to release patient information to their insurance company (if required).
- Identify diagnosis and corresponding facility and/or physician billing codes.
- Include documentation supporting the need for the intended procedure or service and any prior testing with results.
Step 2: Contact the Payer
- Confirm eligibility and benefits.
- Inquire about coverage for the intended procedure or service.
- Determine payer policy requirements for prior authorization. If prior authorization is not required, inquire if a predetermination can be filed.
Verbal authorization may be given based on the information above. Written authorization is preferred. Whether authorization is verbal or written, obtain an authorization number. For written authorization, provide any required prior authorization form(s) for the payer and/or a letter of medical necessity along with supporting documentation and prior testing results.
Step 3: Send the Requested Information
Gather all requested materials and mail, fax, or submit online through the payer website to the department responsible for the prior authorization decisions.
Step 4: Follow-up
Call the payer to verify receipt of the prior authorization request and continue to follow up routinely with the payer until a coverage decision has been made and communicated back to you.
Step 5: Re-verify Eligibility
When the prior authorization has been granted, obtain the prior authorization number and expiration date for your files and request an official approval correspondence. Re-verify the patient's eligibility to confirm that the patient is still covered by this payer and that the patient's plan has not changed.
Step 6: If Necessary, Appeal
If the prior authorization is denied, the physician and patient must decide if they want to appeal the decision. For an appeal, be prepared to:
- Review the denial and any information provided by the payer. If no information is provided, request information from the payer regarding their appeal process.
- Send an appeal letter and any required materials as directed by the payer.
- Verify the payer received appeal materials.
- File the appeal within the time limit set by the payer as listed in the denial letter.
- Patients can also submit a personal appeal to their payer or contact their employer for assistance.
Coverage for LINQ Family of ICMs
Traditional Medicare Coverage
For traditional Medicare patients, Medicare has not issued a national coverage determination nor have any contractors issued any local coverage determinations for subcutaneous cardiac rhythm monitors (SCRMs)/implantable loop recorders (ILRs). In the absence of a formal coverage policy, the Social Security Act allows for coverage for Reveal LINQ and LINQ II FDA-labeled indications when the local contractors determine it is medically reasonable and necessary. Traditional Medicare does not require, nor does it provide, prior authorization, and no prior testing requirements are specified. It is the provider's responsibility to document "reasonable and necessary."
Medicare Advantage Coverage
Medicare Advantage plans are required to cover at least what is covered by Traditional Medicare. Therefore, Medicare coverage policies apply to both traditional Medicare and Medicare Advantage (MA) plans. MA plan administrators may have policies and additional requirements such as prior testing and prior authorization. Medtronic recommends that you review the specific payer coverage policies applicable to your patient to verify all the criteria for coverage are met and/or to request a prior authorization. Asking about coverage or requesting authorization after an implant procedure may result in unpaid claims, leaving both the hospital and the physician without compensation.
Non-Medicare Payer Coverage
Non-Medicare payers typically determine coverage for procedures based on any applicable medical policies and prior authorization when indicated. Not all published policies apply to all patients covered by a particular payer. Medtronic recommends that you review the specific payer coverage policies applicable to your patient to verify all the criteria for coverage are met and to request a prior authorization. Asking about coverage or requesting authorization after an implant procedure may result in unpaid claims, leaving both the hospital and the physician without compensation.
Best Practices for Documentation to Substantiate Coverage
Documentation in the patient's medical record must support the medical necessity of all procedures being performed. Some factors to consider including in that documentation might be:
- Any prior incidents, signs, or symptoms that might suggest a history of possible arrhythmia
- Patients who experience transient symptoms such as dizziness, palpitation, syncope, and chest pain that may suggest a cardiac arrhythmia
- Use/type/duration/findings of any prior cardiac monitoring, including any in-hospital cardiac telemetry/monitoring, and/or other prior diagnostic testing
- Any significant risk factors or comorbidities that may affect clinical management
- Any functional impairment that might limit ability to use or activate a monitoring device
- Other alternative diagnostic and/or therapeutic modalities that were considered for this patient but not selected for use
- Potential use and/or impact of the data acquired from the SCRM/ILR on the clinical management of this patient
Coding for LINQ Family of ICMs
The coding information below does not replace seeking coding advice from the payer and/or your own coding staff. The ultimate responsibility for correct coding lies with the provider of services. All diagnosis and procedure codes must be supported by clear documentation within the medical record.
CPT® Codes
The following CPT® codes describe procedures associated with subcutaneous cardiac rhythm monitors (SCRMs)/implantable loop recorders (ILRs). Services rendered will dictate the appropriate coding. These codes may be used by physicians for all services and may be used by facilities when services are rendered in the outpatient hospital or ambulatory surgery center setting. It is the physician's discretion as to what codes to report based on what procedures were performed.
CPT® Code¹ | CPT® Code Description¹ |
---|---|
Subcutaneous Cardiac Rhythm Monitor Procedures (Includes Loop Recorders) | |
33285 | Insertion, subcutaneous cardiac rhythm monitor, including programming |
33286 | Removal, subcutaneous cardiac rhythm monitor |
Subcutaneous Cardiac Rhythm Monitor Interrogation — In person | |
93291 | Interrogation device evaluation (in person) with analysis, review, and report by a physician or other qualified healthcare professional, includes connection, recording, and disconnection per patient encounter; subcutaneous cardiac rhythm monitor system, including heart rhythm-derived data analysis |
Subcutaneous Cardiac Rhythm Monitor Programming — In person | |
93285 | Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review, and report by a physician or other qualified healthcare professional; subcutaneous cardiac rhythm monitor system |
Subcutaneous Cardiac Rhythm Monitor Interrogation — Remote | |
93298 | Interrogation device evaluation(s), (remote) up to 30 days; subcutaneous cardiac rhythm monitor system, including analysis of recorded heart rhythm data, analysis, review(s), and report(s) by a physician or other qualified healthcare professional |
G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support, and distribution of results |
Subcutaneous Cardiac Rhythm Monitor Programming — Remote | |
0650T (Effective July 1, 2021) | Programming device evaluation (remote) of subcutaneous cardiac rhythm monitor system, with iterative adjustment of the implantable device to test the function of the device and select optimal permanently programmed values with analysis, review and report by a physician or other qualified healthcare professional |
HCPCS Codes (C-codes)
Medicare provides device C-codes for hospital use in billing Medicare for medical devices in the outpatient setting. The following HCPCS device C-code relates to the implantation of subcutaneous cardiac rhythm monitors.
HCPCS Code | HCPCS Code Description |
---|---|
C1764 | Event recorder, cardiac (implantable) |
ICD-10-PCS Procedure Codes
Hospitals assign ICD-10-PCS codes for procedures performed during an inpatient admission. The following ICD-10-PCS codes describe commonly performed subcutaneous cardiac rhythm monitor procedures.
ICD-10-PCS Code | ICD-10-PCS Code Description |
---|---|
Insertion of monitoring device | |
0JH632Z | Insertion of monitoring device into chest subcutaneous tissue and fascia, percutaneous approach |
Removal of monitoring device | |
0JPTO2Z | Removal of monitoring device from trunk subcutaneous tissue and fascia, percutaneous approach |
0JPT32Z | Removal of monitoring device from trunk subcutaneous tissue and fascia, open approach |
ICD-10-CM Diagnosis Codes
Hospitals and other providers assign ICD-10-CM codes to indicate a patient's diagnosis or clinical status. The following is a list of examples of possible ICD-10-CM diagnosis codes that may relate to indications associated with subcutaneous cardiac rhythm monitor procedures. This is not an all-inclusive list and the diagnosis codes reported should be based on documentation appropriate to individual patient presentation.
ICD-10-CM Diagnosis Code | ICD-10-CM Diagnosis Code Description |
---|---|
Stroke and Transient Ischemic Attack | |
I63.0-I63.9 | Acute ischemic stroke |
G45.0-G45.3, G45.8-G45.9 | Transient cerebral ischemic attacks and related syndromes |
I69.30-I69.998 | Sequelae of cerebral infarction (late effect of ischemic stroke) and other cerebrovascular disease |
Z86.73 | Personal history of transient ischemic attack (TIA), and cerebral infarction without residual deficits |
Suspected Arrhythmia: Syncope/Pre-syncope | |
R00.2 | Palpitations |
R42 | Dizziness and giddiness (light-headedness) |
R55 | Syncope and collapse (pre-syncope) |
R94.31 | Abnormal electrocardiogram (ECG) (EKG) |
Suspected Arrhythmia: Atrial Fibrillation | |
R00.2 | Palpitations |
R06.02 | Shortness of breath |
R07.89 | Other chest pain (includes chest pressure, discomfort, and tightness) |
R07.9 | Chest pain, unspecified |
R42 | Dizziness and giddiness (light-headedness) |
R53.83 | Other fatigue (includes lack of energy, tiredness) |
R55 | Syncope and collapse (includes fainting, pre-syncope, and near-collapse) |
R94.31 | Abnormal electrocardiogram (ECG) (EKG) |
Monitoring of Known Atrial Fibrillation | |
I48.0 | Paroxysmal atrial fibrillation |
I48.11 | Longstanding persistent atrial fibrillation |
I48.19 | Other persistent atrial fibrillation |
I48.20 | Chronic atrial flutter, unspecified |
I48.21 | Permanent atrial fibrillation |
I48.91 | Unspecified atrial fibrillation |
Z79.01 | Long-term (current) use of anticoagulants |
Monitoring of Other Known Arrhythmias | |
I47.0 | Reentry ventricular arrhythmia |
I47.1 | Supraventricular tachycardia |
I47.2 | Ventricular tachycardia |
I47.9 | Paroxysmal tachycardia, unspecified |
I48.3 | Typical atrial flutter |
I48.4 | Atypical atrial flutter |
I48.92 | Unspecified atrial flutter |
I49.01 | Ventricular fibrillation |
I49.02 | Ventricular fibrillation |
I49.1 | Atrial premature depolarization (premature atrial beats and contractions) |
I49.2 | Junctional premature depolarization |
I49.3 | Ventricular premature depolarization (premature ventricular contractions) |
Payment for LINQ Family of ICMs
The following information reflects the Medicare national allowable amount published by CMS and does not include Medicare payment reductions resulting from sequestration adjustments to the amount payable to the provider, as mandated by the Budget Control Act of 2011. The Medtronic Customer Economics and Reimbursement teams can provide current site-specific information upon request.
Physician Coding and Payment
Effective Jan. 1, 2021–Dec. 31, 2021
Physicians use CPT® codes to represent procedures and services performed in all places of service. Under Medicare's methodology for physician payment, each CPT® code is assigned a value, known as relative value units (RVUs). RVUs are part of how Medicare determines a payment amount.
Procedure | CPT® Code¹ | Modifier | CPT® Description | 2021 Medicare National Non-facility | 2021 Medicare National Facility | ||
---|---|---|---|---|---|---|---|
Total RVUs¹⁰ | Payment Rate¹⁰ | Total RVUs¹⁰ | Payment Rate¹⁰ | ||||
Subcutaneous Cardiac Rhythm Monitor Procedures (includes Loop Recorders) | 33285 | Insertion, subcutaneous cardiac rhythm monitor, including programming | 149.03 | $5,200 | 2.58 | $90 | |
33286 | Removal, subcutaneous cardiac rhythm monitor | 4.04 | $141 | 2.55 | $89 | ||
Subcutaneous Cardiac Rhythm Monitor Interrogation — In person | 93291 | Interrogation device evaluation (in person) with analysis, review, and report by a physician or other qualified healthcare professional, includes connection, recording, and disconnection per patient encounter; subcutaneous cardiac rhythm monitor system, including heart rhythm-derived data analysis | 1.41 | $49 | N/A | N/A | |
93291 | 26 | 0.53 | $18 | 0.53 | $18 | ||
93291 | TC | 0.88 | $31 | N/A | N/A | ||
Subcutaneous Cardiac Rhythm Monitor Programming — In person | 93285 | Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review, and report by a physician or other qualified healthcare professional; subcutaneous cardiac rhythm monitor system | 1.73 | $60 | N/A | N/A | |
93285 | 26 | 0.75 | $26 | 0.75 | $26 | ||
93285 | TC | 0.98 | $34 | N/A | N/A | ||
Subcutaneous Cardiac Rhythm Monitor Interrogation — Remote | 93298 | Interrogation device evaluation(s), (remote) up to 30 days; subcutaneous cardiac rhythm monitor system, including analysis of recorded heart rhythm data, analysis, review(s), and report(s) by a physician or other qualified healthcare professional | 0.77 | $27 | 0.77 | $27 | |
G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support, and distribution of results | Contractor-priced* | Contractor-priced* | ||||
Subcutaneous Cardiac Rhythm Monitor Programming — Remote | 0650T (Effective July 1, 2021) | Programming device evaluation (remote) of subcutaneous cardiac rhythm monitor system, with iterative adjustment of the implantable device to test the function of the device and select optimal permanently programmed values with analysis, review and report by a physician or other qualified healthcare professional | Contractor-priced* | Contractor-priced* |
Hospital Outpatient Payment
Effective Jan. 1, 2021–Dec. 31, 2021
Hospitals use CPT® codes for outpatient services. The procedure codes below apply to services performed in the hospital outpatient setting.
Under Medicare's Ambulatory Payment Classification (APC) methodology for hospital outpatient payment, each CPT® code is assigned to an ambulatory payment class. Each APC has a relative weight that is then converted to a flat payment amount.
CPT® Code¹ | CPT® Description | 2021 APC¹¹ | APC Title¹¹ | Status Indicator¹¹ | Relative Weight¹¹ | 2021 Medicare National Unadjusted Rate¹¹ |
---|---|---|---|---|---|---|
Subcutaneous Cardiac Rhythm Monitor Procedures (Includes Loop Recorders) | ||||||
33285 | Insertion, subcutaneous cardiac rhythm monitor, including programming | 5222 | Level 2 Pacemaker and Similar Procedures | J1 | 98.46 | $8,153 |
33286 | Removal, subcutaneous cardiac rhythm monitor | 5071 | Level 1 Excision/Biopsy/Incision and Drainage | Q2 | 7.51 | $622 |
CPT® Code¹ | CPT® Description | 2021 APC¹¹ | APC Title¹¹ | Status Indicator¹¹ | Relative Weight¹¹ | 2021 Medicare National Unadjusted Rate¹¹ |
---|---|---|---|---|---|---|
Subcutaneous Cardiac Rhythm Monitor Programming — In person | ||||||
93285 | Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review, and report by a physician or other qualified healthcare professional; subcutaneous cardiac rhythm monitor system | 5741 | Level 1 Electronic Analysis of Devices | Q1 | 0.45 | $37 |
93291 | Interrogation device evaluation (in person) with analysis, review and report by a physician or other qualified healthcare professional, includes connection, recording and disconnection per patient encounter; subcutaneous cardiac rhythm monitor system, including heart rhythm derived data analysis | 5731 | Level 1 Minor Procedures | Q1 | 0.30 | $25 |
CPT® Code¹ | CPT® Description | 2021 APC¹¹ | APC Title¹¹ | Status Indicator¹¹ | Relative Weight¹¹ | 2021 Medicare National Unadjusted Rate¹¹ |
---|---|---|---|---|---|---|
Subcutaneous Cardiac Rhythm Monitor Interrogation — Remote | ||||||
93298 | Interrogation device evaluation(s), (remote) up to 30 days; subcutaneous cardiac rhythm monitor system, including analysis of recorded heart rhythm data, analysis, review(s), and report(s) by a physician or other qualified healthcare professional | N/A | N/A | M | N/A | Physician Only |
G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support, and distribution of results | 5741 | Level 1 Electronic Analysis of Devices | Q1 | 0.45 | $37 |
Subcutaneous Cardiac Rhythm Monitor Programming — Remote | ||||||
0650T (Effective July 1, 2021) | Programming device evaluation (remote) of subcutaneous cardiac rhythm monitor system, with iterative adjustment of the implantable device to test the function of the device and select optimal permanently programmed values with analysis, review and report by a physician or other qualified healthcare professional | N/A | N/A | N/A | N/A | N/A |
Ambulatory Surgical Center (ASC) Payment
Effective Jan. 1, 2021–Dec. 31, 2021
ASCs use CPT® codes for their services. Medicare payment for procedures performed in an ambulatory surgery center is generally based on Medicare's ambulatory payment classification (APC) methodology for hospital outpatient payment. However, comprehensive APCs are used only for hospital outpatient services and are not applied to procedures performed in ASCs. Alternately, payment for some CPT codes is based on the physician fee schedule payment, particularly for procedures commonly performed in the physician office.
Each CPT code designated as an approved procedure in an ASC is assigned a comparable relative weight as under the hospital outpatient APC system. This is then converted to a flat payment amount using a formula unique to ASCs. Multiple procedures can be paid for each claim. Certain ancillary services, such as imaging, may also be reimbursed when they are integral to an approved surgical procedure. Some of these ancillary services are not separately payable. There is no separate payment for these devices in the ASC setting; their payment is included in the payment for the procedure.
CPT® Code¹ | CPT® Description | Subject to Multiple Procedure Discounting¹² | 2021 Medicare National Unadjusted Payment Rate¹² |
---|---|---|---|
33285 | Insertion, subcutaneous cardiac rhythm monitor, including programming | Y | $7,046 |
33286 | Removal, subcutaneous cardiac rhythm monitor | N | $316 |
All other applicable CPT codes for SCRM are not payable in the ASC setting, and are not listed here.
Hospital Inpatient Payment
Effective Oct. 1, 2020–Sept. 30, 2021
Medicare reimbursement for inpatient hospital services is based on a classification system known as Medicare severity diagnosis related groups (MS-DRGs). MS-DRG assignment is determined by patient diagnoses and procedures. Only one MS-DRG is assigned per hospital admission, and one payment is made for all procedures and supplies related to that inpatient stay. MS-DRG assignment may be affected when one or more secondary diagnoses that are included in the major complication or comorbidity (MCC) or complication or comorbidity (CC) lists, which are maintained by CMS. Each MS-DRG has a relative weight that is then converted to a flat payment amount. Only one MS-DRG is assigned for each inpatient stay, regardless of the number of procedures performed.
The MS-DRGs shown are those typically assigned to the following scenarios
MS-DRG¹⁴ | MS-DRG Description | FY2021 MS-DRG Medicare National Unadjusted Payment Rate¹³ |
---|---|---|
SCRM Insertion during an Admission for Cryptogenic Stroke | ||
040 | Peripheral/cranial nerve and other nervous system procedures with MCC | $25,439 |
041 | Peripheral/cranial nerve and other nervous system procedures with CC or peripheral neurostimulator | $15,112 |
042 | Peripheral/cranial nerve and other nervous system procedures without CC/MCC | $12,115 |
SCRM Insertion during an Admission for Syncope | ||
260 | Cardiac pacemaker revision except device replacement with MCC | $23,038 |
261 | Cardiac pacemaker revision except device replacement with CC | $12,799 |
262 | Cardiac pacemaker revision except device replacement without CC/MCC | $10,979 |
Frequently Asked Questions
Insertion & Removal Coding and Payment
-
When subcutaneous cardiac rhythm monitor (SCRM)/implantable loop recorder (ILR) insertion is performed in the outpatient hospital during the same episode of care as another procedure (for example, cardiac ablation), how is payment affected?
Hospital Outpatient Payment:
- Medicare reimburses device-intensive procedures performed in the hospital outpatient setting using Comprehensive Ambulatory Payment Classifications (C-APCs) payment rates. Under C-APCs, if two procedures designated by Medicare as included in C-APCs are performed concurrently, the procedure with the highest-weighted C-APC will be paid to the hospital. C-APCs package all supplies and services during that episode into one single payment.
- When an AF ablation and SCRM/ILR implant are both performed, only one C-APC reimbursement will be paid to the hospital. In this case, the AF ablation C-APC amount will be paid, as it is the higher-weighted procedure. No additional reimbursement payment for inserting the SCRM/ILR would be made to the hospital.
Physician Payment:
- Medicare physician payment is determined using the multiple procedure reduction rule. For concurrent procedures, the physician will be reimbursed the full fee schedule amount for the highest-weighted procedure and will be reimbursed at 50% of the fee schedule amount for all additional procedures.
- When an AF ablation and SCRM/ILR implant are both performed at the same time, the AF ablation will be paid at 100% of the fee schedule amount and the SCRM/ILR reimbursement insertion will be paid at 50% of the fee schedule amount when the payer determines coverage criteria have been met.
-
Can non-physician practitioners (NPPs), such as nurse practitioners (NPs) and physician assistants (PAs), perform SCRM/ILR insertion & removal procedures?
On or after January 1, 2019, CMS may cover an insertion/removal when performed by an NPP if the following criteria are all fulfilled:
- The procedure is within the scope of practice of the license for the state in which the NPP practices.
- Payer rules must be followed. Payers may or may not allow insertions by NPPs, and the NPP needs to research each payer to obtain policy requirements, supervision rules, and the approval process.
- The NPP must meet the credentialing and supervision requirements at the location where the implant will occur.
- Also consider whether malpractice insurance covers the NPP for performing the insertion/removal procedures. Refer to CMS Publication 100-02, Medicare Benefit Policy Manual, Chapter 15, for non-physician practitioner rules.
-
When an insertion takes place in an office, how is the office reimbursed for the cost of the device?
The device cost is included in the global Medicare PFS non-facility amount paid to the office for the insertion procedure.
-
Is there a global surgical period that applies for the insertion or removal of SCRM/ILR?
No, these codes are considered minor surgical procedures, which do not have a global period.
-
What code should be reported when SCRM/ILR requires repositioning?
CPT does not have an established code that accurately describes repositioning of SCRM/ILR. The provider may consider using either 17999 (Unlisted procedure, skin, mucous membrane and subcutaneous tissue) or 33999 (Unlisted procedure, cardiac surgery). When reporting either of these codes, a description of the procedure performed must also be included on the claim form. The payer will determine coverage.
-
What codes would be reported when an SCRM/ILR is replaced?
The removal would be reported with 33286 and the placement of the new SCRM/ILR is reported with 33285. There are CCI edits for this coding combination. A modifier would be required for the removal ONLY when there is documentation that supports billing both codes. The payer will determine coverage.
Monitoring Coding and Payment
-
What code is used to report the technical component of remote monitoring and how is it reimbursed?
In 2020, CPT 93299 was deleted and replaced with HCPCS G2066. For traditional Medicare patients, HCPCS G2066 is contractor-priced, meaning the code is not assigned a rate on a national level. Local contractors will determine the reimbursement amount on a case-by-case basis. For private payers, including Medicare Advantage, we recommend contacting the payer to determine appropriate coding and associated payment.
-
What code would be reported when an SCRM/ILR is programmed remotely?
Beginning July 1, 2021, CPT code 0650T will accurately describe remote programming of an SCRM/ILR. See "2021 UPDATES" section for more information.
-
What is the minimum number of days that the SCRM/ILR patient need to be remoted monitored for the services to be billable?
The patient must be monitored for a minimum of 10 days of the full 30-day service period to meet the requirements to bill.
-
Can a provider bill additionally for each SCRM/ILR transmission reviewed during a remote monitoring period?
No, SCRM/ILR remote monitoring codes are time-based and represent all work that occurs over a 30-day period. There is one payment made for the 30-day episode, regardless of the number of times that data is transmitted and/or reviewed.
-
Is billing affected if an SCRM/ILR patient receives an in-person interrogation evaluation during a 30-day remote monitoring period?
In-person interrogation services are not separately reportable during the same period when remote monitoring is being performed. Only the remote monitoring service is billable (CPT code 93298 for the professional service and G2066 for the technical service). If the patient receives in-person interrogation services during the remote monitoring period, this is not separately reportable or payable.
-
Is billing affected if an SCRM/ILR patient receives an in-person programming evaluation during a 30-day remote monitoring period?
When an in-person programming evaluation is performed during the remote 30-day episode, the programming evaluation may be separately billed. The payer will determine coverage based on documented medical necessity.
-
What components of an SCRM/ILR must be evaluated during interrogation evaluation services?
The required components are the same for both remote and in-person interrogation:
- All programmed parameters
- Heart rate and rhythm during recorded episodes from both patient-initiated and device algorithm-detected events, when present
Additional Information
Visit our website: http://www.medtronic.com/crhfreimbursement
Email us: rs.healthcareeconomics@medtronic.com
Call our Reimbursement Customer Support: 1.866.877.4102
Brief Statement
Reveal LINQ™ and LINQ II™ Insertable Cardiac Monitors with Reveal LINQ™ Mobile Manager System
Indications
The Reveal LINQ and LINQ II Insertable Cardiac Monitors (ICMs) are insertable automatically activated and patient-activated monitoring systems that record subcutaneous ECG and are indicated in the following cases:
- Patients with clinical syndromes or situations at increased risk of cardiac arrhythmias
- Patients who experience transient symptoms such as dizziness, palpitation, syncope, and chest pain that may suggest a cardiac arrhythmia.
The device has not been tested specifically for pediatric use.
Reveal LINQ™ Mobile Manager System
The Reveal LINQ Mobile Manager app is intended for programming and interrogating the Reveal LINQ and LINQ II Insertable Cardiac Monitors. The patient connector is intended to be used with Medtronic apps to interrogate, analyze, and/or program implantable Medtronic devices. The patient connector uses Bluetooth® technology to transmit data to the Reveal LINQ Mobile Manager app for further processing. The patient connector is intended for use by healthcare professionals in a clinical or hospital environment.
Contraindications
There are no known contraindications for the implant of the Reveal LINQ Insertable Cardiac Monitor. However, the patient's particular medical condition may dictate whether or not a subcutaneous, chronically implanted device can be tolerated.
Warnings and Precautions
Reveal LINQ and LINQ II Insertable Cardiac Monitors
Patients with the Reveal LINQ and LINQ II ICMs should avoid sources of diathermy, high sources of radiation, electrosurgical cautery, external defibrillation, lithotripsy, therapeutic ultrasound, and radiofrequency ablation to avoid electrical reset of the device, and/or inappropriate sensing as described in the Medical Procedure and EMI Warnings, Precautions, and Guidance manual. MRI scans should be performed only in a specified MR environment under specified conditions as described in the Reveal LINQ or LINQ II MRI Technical Manual.
Reveal LINQ Mobile Manager System
Before inserting the device, verify that the patient connector and tablet are fully charged. The patient connector and tablet may run out of power during the insertion procedure if they are not fully charged. You will not be able to program or interrogate the patient's device until the patient connector and the tablet have power.
- Only use the patient connector to communicate with the intended implanted device.
- Use of wireless devices - The patient connector incorporates radiofrequency (RF) communications components which may affect other devices and equipment in the medical environment.
- Radiofrequency (RF) interference - Portable and mobile RF communications equipment can interfere with the operation of the patient connector. There is no guarantee that it will not receive interference or that any particular transmission from this system will be free from interference.
- Security - Maintain adequate physical security of the patient connector to prevent unauthorized use that could lead to harm to patients.
- Environmental precautions - To ensure safe and effective operation, use the device with care to avoid damage to the patient connector from environmental factors that may impair its function.
References
1 CPT codes and descriptions only are copyright ©2020 American Medical Association. All rights reserved. No fee schedules are included in CPT. The American Medical Association assumes no liability for data contained or not contained herein.
2 CY 2021 Payment Policies under the Physician Fee Schedule and Other Changes to Part B Payment Policies. Display Copy: https://public-inspection.federalregister.gov/2020-26815.pdf. Accessed December 8, 2020.
3 Social Security Act Section 1862 42 U.S.C. 1395y(a)(1)(A). Available at: https://www.ssa.gov/OP_Home/ssact/title18/1862.htm. Accessed December 17, 2020.
4 Centers for Medicare & Medicaid Services. Medicare Program Integrity Manual. Available at: https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/Downloads/pim83c03.pdf. Accessed December 17, 2020.
5 Centers for Medicare and Medicaid Services. Medicare Managed Care Coverage Manual - Chapter 4 section 10.7.1 and 10.7.3 https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/downloads/mc86c04.pdf. Accessed on December 17, 2020.
6 CMS has posted a "Clinical Concepts in Cardiology" tip sheet on their website identifying several clinical documentation tips for Cardiology services and ICD-10-CM diagnosis codes. https://www.cms.gov/Medicare/Coding/ICD10/Downloads/ICD10ClinicalConceptsCardiology1.pdf. The resource includes common codes, clinical documentation tips, and clinical scenarios. Please review the CMS document on Clinical Concepts in Cardiology for complete information, keeping in mind this document is from 2015, and codes may have been revised or updated since its publication.
7 Device C-codes are HCPCS Level II codes and also maintained by the Centers for Medicare and Medicaid Services. Healthcare Common Procedure Coding System. http://www.cms.gov/Medicare/Coding/HCPCSReleaseCodeSets/Alpha-Numeric-HCPCS.html. Accessed December 17, 2020
8 Centers for Medicare and Medicaid Services. 2021 ICD-10-PCS. cms.gov. https://www.cms.gov/medicare/icd-10/2021-icd-10-pcs. Updated December 2, 2020. Accessed December 3, 2020.
9 Centers for Disease Control and Prevention, National Center for Health Statistics. International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM). https://www.cdc.gov/nchs/icd/icd10cm.htm. Accessed December 17, 2020.
10 The Medicare Physician Fee Schedule (MPFS) 2021 National payment rates based on information published in the MPFS final rule CMS-1734-F and updated due to legislation that was signed December 27, 2020 including corresponding tables and which were updated on December 29, 2020. PFS Federal Regulation Notices. cms.gov. https://www.cms.gov/medicare/medicare-fee-service-paymentphysicianfeeschedpfs-federal-regulation-notices/cms-1734-f. Accessed December 3, 2020. Local physician rates will vary based on location specific factors not reflected in this document. CMS may make adjustments to any or all of the data inputs from time to time.
11 The OPPS 2021 National payment rates based on information published in the OPPS/ASC final rule CMS-1736-FC and corresponding Addendum B table which was published on December 3, 2020. Hospital Outpatient Regulations and Notices. cms.gov. https://www.cms.gov/medicare/medicare-fee-service-paymenthospitaloutpatientppshospital-outpatient-regulations-and-notices/cms-1736-fc. Accessed December 3, 2020. Hospital specific rates will vary based on various hospital-specific factors not reflected in this document and CMS may make adjustments to any or all of the data inputs from time to time.
12 The Ambulatory Surgical Center (ASC) ASC 2021 National payment rates based on information published in the OPPS/ASC final rule CMS-1736-FC, Addendum AA table which was published on December 3, 2020. ASC Regulations and Notices. cms.gov. https://www.cms.gov/medicare/medicare-fee-service-paymentascpaymentasc-regulations-and-notices/cms-1736-fc. Accessed December 3, 2020. ASC specific rates will vary based on various specific factors not reflected in this document and CMS may make adjustments to any or all of the data inputs from time to time.
13 The IPPS FY 2021 National payment rates based on information published in the IPPS final rule CMS-1735-F and correction notice CMS-1735-CN and corresponding tables and data files which was published on September 18, 2020. IPPS Final Rule Home Page. cms.gov. https://www.cms.gov/medicare/acute-inpatient-pps/fy-2021-ipps-final-rule-home-page. Updated December 3, 2020. Accessed December 4, 2020. Hospital specific rates will vary based on various hospital-specific factors not reflected in this document and CMS may make adjustments to any or all of the data inputs from time to time.
14 ICD-10-CM/PCS MS-DRG v38.0 Definitions Manual. Cms.gov. https://www.cms.gov/icd10m/version38-fullcode-cms/fullcode_cms/P0001.html. Accessed December 17, 2020.
15 Centers for Medicare and Medicaid Services. Publication 100-04 Medicare Claims Processing Manual, Chapter 12 Physician/NonPhysician Practitioners. Available at: https://www.cms.gov/Regulations-and-Guidance/ Guidance/Manuals/Downloads/clm104c12.pdf. Accessed December 17, 2020.
16 Centers for Medicare and Medicaid Services. Publication 100-02: Medicare Benefit Policy Manual, Chapter 15: Covered Medical and Other Health Services. Available at: https://www.cms.gov/Regulations-and-Guidance/ Guidance/Manuals/Internet-Only-Manuals-IOMs-Items/CMS012673. Accessed December 17, 2020.
17 American Medical Association. 2021 CPT Professional Edition. Details may be found in the Cardiovascular Monitoring section.